Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Stefanetti

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of the American Association of Gynecologic Laparoscopists|May 7, 2003
Heterotopic pregnancyMarco Stefanetti, Giuseppe Comerci, Carlo Bulletti
Fertility and Sterility|October 24, 2007
Isolated fallopian tube torsion: a rare but important event for women of reproductive ageGiuseppe Comerci, Filippo Maria Colombo, Marco Stefanetti, et al.
Annals of the New York Academy of Sciences|February 26, 2005
Myomas, pregnancy outcome, and in vitro fertilizationCarlo Bulletti, Dominique DE Ziegler, Paolo Levi Setti, et al.
Maturitas|December 14, 2020
Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?Giovanni Grandi, Anna Myriam Perrone, Antonino Perrone, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2018
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional StudyFrancesco Raspagliesi, Giorgio Bogani, Laura Matteucci, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 29, 2019
RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapyGiorgio Bogani, Laura Matteucci, Stefano Tamberi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2017
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional StudyGiorgio Bogani, Laura Matteucci, Stefano Tamberi, et al.
Frontiers in Oncology|September 4, 2023
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patientsAlberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, et al.
Cancers|April 14, 2026
Impact of Facility Volume on Therapy and Survival for Endometrial Cancer: A Retrospective Multicenter StudyVincenzo Dario Mandato, Anna Myriam Perrone, Debora Pirillo, et al.
Cancers|July 12, 2025
Impact of a Surgical Approach on Endometrial Cancer Survival According to ESMO/ESGO Risk Classification: A Retrospective Multicenter Study in the Northern Italian RegionVincenzo Dario Mandato, Anna Myriam Perrone, Debora Pirillo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of the American Association of Gynecologic Laparoscopists|May 7, 2003
Heterotopic pregnancyMarco Stefanetti, Giuseppe Comerci, Carlo Bulletti
Fertility and Sterility|October 24, 2007
Isolated fallopian tube torsion: a rare but important event for women of reproductive ageGiuseppe Comerci, Filippo Maria Colombo, Marco Stefanetti, et al.
Annals of the New York Academy of Sciences|February 26, 2005
Myomas, pregnancy outcome, and in vitro fertilizationCarlo Bulletti, Dominique DE Ziegler, Paolo Levi Setti, et al.
Maturitas|December 14, 2020
Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?Giovanni Grandi, Anna Myriam Perrone, Antonino Perrone, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2018
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional StudyFrancesco Raspagliesi, Giorgio Bogani, Laura Matteucci, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 29, 2019
RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapyGiorgio Bogani, Laura Matteucci, Stefano Tamberi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2017
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional StudyGiorgio Bogani, Laura Matteucci, Stefano Tamberi, et al.
Frontiers in Oncology|September 4, 2023
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patientsAlberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, et al.
Cancers|April 14, 2026
Impact of Facility Volume on Therapy and Survival for Endometrial Cancer: A Retrospective Multicenter StudyVincenzo Dario Mandato, Anna Myriam Perrone, Debora Pirillo, et al.
Cancers|July 12, 2025
Impact of a Surgical Approach on Endometrial Cancer Survival According to ESMO/ESGO Risk Classification: A Retrospective Multicenter Study in the Northern Italian RegionVincenzo Dario Mandato, Anna Myriam Perrone, Debora Pirillo, et al.
Pageof 1